Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on ABIVAX mainly cover share price moves, analyst notes et M&A activity. The stock trades at €112,80 on Euronext Paris, down 1,48% at the last update. This page lists the articles published on ABIVAX stock to track the share price, company announcements and any item likely to influence market perception.
After an extraordinary twelve-month stock market performance, the French biotech takes a new pause during the session. The stock is among the largest …
The French biotech takes a brief pause after an extraordinary twelve-month stock market journey. The stock dips in early afternoon in a balanced Paris…
The French biotech takes a new break during the session, in a Parisian market heavily affected by the resurgence of tensions in the Middle East. Howev…
The French biotech consolidates during the session, just days after securing its financing in the United States. The stock remains technically overhea…
French biotech company Abivax has announced the completion of its public offering of American Depositary Shares (ADS) in the United States, raising a …
The French biotech resumes trading in Paris with a strong increase, following the completion of its ADS offering in the United States. The stock takes…
French biotech company Abivax announces a temporary suspension of the trading of its ordinary shares on Euronext Paris starting from the opening, as p…
French biotech company Abivax has announced the launch of a public offering of American Depositary Shares (ADS) amounting to approximately $600 millio…
The French biotech company had a spectacular mid-day trading session, catapulting to the top of the broad Paris index. The stock erased several weeks …
Abivax has announced positive results from Part 2 of the ABTECT maintenance trial, showing that its candidate obefazimod restores clinical remission i…
